Peloton Therapeutics
Dallas
About Peloton Therapeutics
A peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton's vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $242.6M
- Funding stage: M&A
- Last round: Series E (Feb 2019)
- Website: pelotontherapeutics.com
- Phone: 972-629-4100
Industries & Categories
Biotechnology, Health Care, Medical Device, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/peloton-therapeutics-130161 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.